Goldman Sachs Group Inc Bristol Myers Squibb CO Transaction History

Goldman Sachs Group Inc

$555 Billion
Q1 2024

A detailed history of Goldman Sachs Group Inc transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Goldman Sachs Group Inc holds 15,971,559 shares of BMY stock, worth $656 Million. This represents 0.16% of its overall portfolio holdings.

Number of Shares

15,971,559

Previous 16,359,536 2.37%

Holding current value

$656 Million

Previous $839 Million 3.18%

% of portfolio

0.16%

Previous 0.16%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$47.98 - $54.4 $18.6 Million - $21.1 Million	-387,977 Reduced 2.37%	15,971,559 $866 Million
Q4 2023 Feb 13, 2024	SELL	$48.48 - $57.85 $47.7 Million - $57 Million	-984,542 Reduced 5.68%	16,359,536 $839 Million
Q3 2023 May 14, 2024	BUY	$57.89 - $64.73 $57 Million - $63.7 Million	984,542 Added 6.02%	17,344,078 $1.01 Billion
Q3 2023 Nov 14, 2023	BUY	$57.89 - $64.73 $48.6 Million - $54.4 Million	840,138 Added 5.09%	17,344,078 $1.01 Billion
Q2 2023 May 14, 2024	SELL	$63.71 - $70.74 $42.7 Million - $47.4 Million	-669,878 Reduced 3.9%	16,503,940 $1.06 Billion

Q2 2023 Aug 14, 2023	SELL	$63.71 - $70.74 $42.7 Million - $47.4 Million	-669,878 Reduced 3.9%	16,503,940 $1.06 Billion
Q1 2023 May 14, 2024	BUY	$65.71 - $74.53 $96.6 Million - $110 Million	1,470,325 Added 9.36%	17,173,818 $1.19 Billion
Q1 2023 May 11, 2023	BUY	$65.71 - $74.53 $96.6 Million - $110 Million	1,470,325 Added 9.36%	17,173,818 $1.19 Billion
Q4 2022 May 14, 2024	BUY	$68.48 - $81.09 $11.1 Million - $13.1 Million	162,073 Added 1.04%	15,703,493 $1.13 Billion
Q4 2022 Feb 13, 2023	BUY	$68.48 - $81.09 $11.1 Million - $13.1 Million	162,073 Added 1.04%	15,703,493 $1.13 Billion
Q3 2022 May 14, 2024	BUY	$0.13 - $76.84 $153,961 - $91 Million	1,184,317 Added 8.25%	15,541,420 $1.1 Billion
Q3 2022 Nov 10, 2022	BUY	$0.13 - $76.84 $153,961 - $91 Million	1,184,317 Added 8.25%	15,541,420 $1.1 Billion
Q2 2022 May 14, 2024	SELL	$72.62 - $79.98 $145 Million - $160 Million	-2,002,433 Reduced 12.24%	14,357,103 $1.11 Billion
Q2 2022 Aug 15, 2022	SELL	$72.62 - $79.98 $127 Million - $140 Million	-1,751,823 Reduced 10.87%	14,357,103 $1.11 Billion
Q1 2022 May 16, 2022	BUY	$61.48 - $73.72 $253 Million - $303 Million	4,114,062 Added 34.3%	16,108,926 $1.18 Billion
Q4 2021 Feb 14, 2022	SELL	$53.63 - $62.52 $122 Million - $142 Million	-2,270,599 Reduced 15.92%	11,994,864 $748 Million
Q3 2021 Nov 10, 2021	BUY	$59.17 - $69.31 $844 Million - $989 Million	14,265,463 New	14,265,463 $844 Million

Others Institutions Holding BMY

# of Institutions

2,552

Shares Held

1.49B

Call Options Held

25.9M

Put Options Held

20M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $87.4B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Account

Goldman Sachs Group Inc Bristol Myers Squibb CO Transaction History